特别提示:包括重组人氧化型低密度脂蛋白受体1(OLR1)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
产品名称:重组人氧化型低密度脂蛋白受体1(OLR1)
英文名称:Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1
产品货号:JN0607
产品规格:10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成,目的基因编码的Ser61-Gln273在C端含有His标签。
OLR1质量控制:>95%(还原性SDS-PAGE)
OLR1制剂:冻干品
OLR1保存:
冻干蛋白置于-20℃以下可长期保存,室温条件下可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天,可分装后置于-20℃保存三个月。
OLR1复溶:
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后,请根据用量分装冻存,避免反复冻融。
关于OLR1:
Oxidized Low-Density Lipoprotein Receptor 1 (Ox-LDL Receptor 1) is a secreted, single-pass type II membrane protein which belo
ngs to the C-type lectin superfamily. Ox-LDL Receptor 1 is expressed at high levels in endothelial cells and vascular-rich organs such as placenta, lung, liver, brain, aortic intima, bone marrow, spinal cord and substantia nigra. The ex
pression of Ox-LDL Receptor 1 is induced by inflammatory cytokines such as TNF, IFNG and IL6 by pathological conditions, such as hyperlipidemia, hypertension and diabetes mellitus. Ox-LDL Receptor 1 mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (OxLDL) by vascular endothelial cells. Ox-LDL Receptor 1 association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular respo
nses including a reduction of nitric oxide (NO) release, mo
nocyte adhesion and apoptosis. Ox-LDL Receptor 1 also binds to oxLDL, which acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. It also participates in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation.
根据您的关注的
重组人氧化型低密度脂蛋白受体1(OLR1),重组人Oxidized Low-Density Lipoprotein Receptor 1,重组OLR1,Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1,重组人氧化型低密度脂蛋白受体1,重组Oxidized Low-Density Lipoprotein Receptor 1,rhOLR1,rOLR1,重组人OLR1,重组氧化型低密度脂蛋白受体1,您可能还对以下产品有需求:
货号
|
名称
|
规格
|
JN0294
|
重组人趋化因子CCL8(MCP-2)
|
10μg|50μg|500μg|1mg
|
JN0401
|
重组人白介素IL-12β
|
10μg|50μg|500μg|1mg
|
JN0419
|
重组小鼠白介素IL-3(C端带His标签)
|
10μg|50μg|500μg|1mg
|
JN0470
|
重组人4-1BBL(TNFSF9)
|
10μg|50μg|500μg|1mg
|
JN2026
|
重组人热反应蛋白12(HRSP12)
|
10μg|50μg|500μg|1mg
|
JN0707
|
重组人小泛素相关修饰物3(SUMO3)
|
10μg|50μg|500μg|1mg
|
关注
重组人氧化型低密度脂蛋白受体1(OLR1),重组人Oxidized Low-Density Lipoprotein Receptor 1,重组OLR1,Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1,重组人氧化型低密度脂蛋白受体1,重组Oxidized Low-Density Lipoprotein Receptor 1,rhOLR1,rOLR1,重组人OLR1,重组氧化型低密度脂蛋白受体1的同时,为您推荐更多您可能感兴趣的产品:
JN0256 重组人酸性FGF1(2-155)(成纤维生长因子1) 10μg|50μg|500μg|1mg
JN0420 重组人Albumin-IFN-α2b(HSA-IFN-α2b) 10μg|50μg|500μg|1mg
JN0441 重组人肿瘤坏死因子-β(TNF-β) 10μg|50μg|500μg|1mg
JN1931 重组人脂肪酸结合蛋白3(FABP3) 10μg|50μg|500μg|1mg
JN1982 重组人膜联蛋白A6(Annexin A6) 10μg|50μg|500μg|1mg
JN2000 重组人γ谷氨酰氨环化转移酶(GGACT) 10μg|50μg|500μg|1mg
JN0622 重组人前梯度同源蛋白3(ARG3) 10μg|50μg|500μg|1mg
本页产品地址:http://www.yi7.com/sell/show-8568193.html